Johnson & Johnson (JNJ) stock rallied over 0.29% intraday to trade at $177.51 a share on NYSE. The stock opened with a gain of 0.16% at $176.86 and touched an intraday high of $178.278, rising 0.29% against the last close of $176.99. The stock went to a low of $175.03 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue94.88 Billion
5Y Sales Change5.50%
Fiscal Year Ends2022-01-01
Johnson & Johnson researches and develops, manufactures, and sells various products in the healthcare field worldwide. It operates in three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and healthcare professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson (NYSE: JNJ) stock price is $177.51 as of the last check on Thursday, June 30. During the trading session, JNJ stock reached the peak price of $178.278 while $175.03 was the lowest point it dropped to.
The NYSE listed JNJ is part of Pharmaceuticals industry that operates in the broader Health Care sector. Johnson & Johnson researches and develops, manufactures, and sells various products in the healthcare field worldwide. It operates in three segments: Consumer Health, Pharmaceutical, and Medical Devices.
Mr. Alex Gorsky
Mr. Joaquin Duato
CEO & Director
Mr. Joseph J. Wolk CPA
Exec. VP & CFO
Ms. Jennifer L. Taubert
Exec. VP & Worldwide Chairman of Pharmaceuticals
JNJ stock traded closed the last session at $177.51, which is $0.52 or 0.29% lower than its previous close of $176.99. JNJ's current trading price is 13.99% lower than its 52-week high of $186.69 where as its distance from 52-week low of 155.72% is -4.92%.
Number of JNJ employees currently stands at -. JNJ operates from One Johnson & Johnson Plaza, New Brunswick, NJ 08933, United States.
Official Webiste of $JNJ is: https://www.jnj.com
JNJ stock volume for the day was 10,776,606 shares while in the previous session number of JNJ shares traded was 10,776,627 . The average number of JNJ shares traded daily for last 3 months was 7.66 Million.
The percentage change in JNJ stock occurred in the recent session was 0.29% while the dollar amount for the price change in JNJ stock was $0.52.
In the recent session, the day high for JNJ stock was $178.278 while the low for JNJ stock touched on the day was $175.03.
The market value of JNJ currently stands at 460.36 Billion with its latest stock price at $177.51 and 2.63 Billion of its shares outstanding.